About This Project
BioPeers – Peers Center for Biotech and Society
Our bodies produce very low doses of N,N-Dimethyltryptamine (DMT), a psychotropic substance. Recent findings suggest that DMT is an important modulator of Sig-1R, a receptor that plays important roles in neuropsychiatric diseases like schizophrenia, and depression. This project aims to further develop a hypothesis for the relation between DMT and Sig-1R, in hopes of providing novel insight into these neuropsychiatric diseases.
Recent Lab Notes From This Project
Browse Other Projects on Experiment
Are current antibacterial treatments resulting in the evolution of more virulent multidrug resistant bacteria?
Each year in the U.S. 23,000 people die as a direct result of antibiotic resistant infections. I hypothesize...
In Saccharomyces cerevisiae, the protein CLN1 forms a complex with the CDK1 in the cell regulatory cycle. Studies...